Biohit Oyj - Company Announcement

Biohit Oyj CEO Semi Korpela takes sick leave

Biohit Oyj Stock Exchange Release January 5, 2017 at 1:00 pm local time (EEST)


Starting from January 5, 2017 Biohit Oyj´s CEO Semi Korpela will take a sick
leave of approximately one month related to pneumonia. 

During Semi Korpela´s sick leave, his deputy will be Biohit Oyj`s CFO Niklas
Nordström. 



Board of Directors



Additional information:

Osmo Suovaniemi, Chairman of the Board of Directors
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com



Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com